Background and Purpose-Energy depletion is a critical factor leading to cell death and brain dysfunction after ischemic stroke. In this study, we investigated whether energy depletion is involved in hyperglycemia-induced hemorrhagic transformation after ischemic stroke and determined the pathway underlying the beneficial effects of hyperbaric oxygen (HBO). Methods-After 2-hour middle cerebral artery occlusion, hyperglycemia was induced by injecting 50% dextrose (6 mL/ kg) intraperitoneally at the onset of reperfusion. Immediately after it, rats were exposed to HBO at 2 atmospheres absolutes for 1 hour. ATP synthase inhibitor oligomycin A, nicotinamide phosphoribosyl transferase inhibitor FK866, or silent mating type information regulation 2 homolog 1 siRNA was administrated for interventions. Infarct volume, hemorrhagic volume, and neurobehavioral deficits were recorded; the level of blood glucose, ATP, and nicotinamide adenine dinucleotide and the activity of nicotinamide phosphoribosyl transferase were monitored; the expression of silent mating type information regulation 2 homolog 1, acetylated p53, acetylated nuclear factor-κB, and cleaved caspase 3 were detected by Western blots; and the activity of matrix metalloproteinase-9 was assayed by zymography. Results-Hyperglycemia deteriorated energy metabolism and reduced the level of ATP and nicotinamide adenine dinucleotide and exaggerated hemorrhagic transformation, blood-brain barrier disruption, and neurological deficits after middle cerebral artery occlusion. HBO treatment increased the levels of the ATP and nicotinamide adenine dinucleotide and consequently increased silent mating type information regulation 2 homolog 1, resulting in attenuation of hemorrhagic transformation, brain infarction, as well as improvement of neurological function in hyperglycemic middle cerebral artery occlusion rats. Conclusions-HBO induced activation of ATP/nicotinamide adenine dinucleotide/silent mating type information regulation 2 homolog 1 pathway and protected blood-brain barrier in hyperglycemic middle cerebral artery occlusion rats. HBO might be promising approach for treatment of acute ischemic stroke patients, especially patients with diabetes mellitus or treated with r-tPA (recombinant tissue-type plasminogen activator). 
T he energy failure caused by lack of glucose and oxygen and consequently by depletion of ATP is one of the major events after cerebral ischemia. It initiates multiple intracellular pathways and results in cell death and blood-brain barrier (BBB) disruption. 1 Neurons, compared with other cell types, have higher energy expenditure and contain little energy reserves. 2 Early restoration of energy greatly contributes to the survival of neurons and determines the outcome of ischemic stroke.
1 About 10% to 40% of patients with ischemic stroke will develop hemorrhagic transformation (HT) and it is more prevalent in patients with glucose metabolism disorders. 3, 4 The only 1 available therapeutic option of ischemic stroke, r-tPA (recombinant tissue-type plasminogen activator), can
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June 2017 also induce HT, significantly restricting the clinical usage of r-tPA. 5, 6 Oxidative cascades, leukocyte infiltration, vascular activation, and disregulated extracellular proteolysis might act as a potential trigger of HT and undermine the integrity of BBB. 7, 8 New therapeutic strategies capable of preserving BBB and ameliorating HT will benefit a significant number of stroke patients.
Though hyperbaric oxygen (HBO) treatment has been reported to reduce hyperglycemia-enhanced HT and r-tPArelated HT in experimental stroke, 9 ,10 the underlying mechanisms remain largely unknown. Nicotinamide adenine dinucleotide (NAD + ) is a classic energy metabolite that is synthesized from its precursors (nicotinic acid and nicotinamide) by the rate-limiting enzyme nicotinamide phosphoribosyl transferase (NAMPT). 11, 12 NAD + positively regulates the activity of silent mating type information regulation 2 homolog 1 (Sirt1) and plays critical roles in neuroprotection after ischemic stroke. 13 HBO increases the expression of Sirt1 14 , but the signaling pathway has not been fully elucidated yet. In the present study, we induced HT by combination of hyperglycemia/ischemia (middle cerebral artery occlusion [MCAO] ) and hypothesized that (1) hyperglycemia induces energy deficits causing HT; (2) HBO activates ATP/NAD + /Sirt1 pathway, resulting in the restored energy level and leading to the improved BBB and neurological functions.
Materials and Methods
This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All protocols were approved by the Institutional Animal Care and Use Committee of Loma Linda University. The model of MCAO on rats was used. A total of 303 adult male Sprague-Dawley rats (2-3 months, weight 250-300 g) were randomly distributed to 11 groups for the study (Table I in the online-only Data Supplement). The investigators are blinded to group assignments during outcome assessments. The experimental design is shown in Figure I in the online-only Data Supplement.
MCAO Animal Model and Hyperglycemia Induction
Transient MCAO was induced as previously described 15 (for details, please see the online-only Data Supplement). Hyperglycemia was induced by injection of 50% dextrose (DX, 6 mL/kg) intraperitoneally at the beginning of reperfusion. The glucose level was monitored at 0, 2, 4, 6, and 8 hours after injection.
HBO Treatment and Drugs
HBO should be applied within 3 to 6 hours when the ischemic neuronal tissues can still be saved. 16 Because of possible toxicity of oxygen, the duration of HBO sessions should ranges from 60 to 90 minutes, and the oxygen pressure should not exceed 3 atmospheres absolutes, whereby the most used pressure range from 1.5 to 3 atmospheres absolutes. 16 In our study, rats were exposed to HBO at 2 atmospheres absolutes for 60 minutes in a research hyperbaric chamber (1300B; Sechrist) at the onset of reperfusion. Compression and decompression were maintained at a rate of 5 psi/minute. NAD + (SigmaAldrich), ATP synthase inhibitor oligomycin A (Olig A; Santa Cruz Biotechnology), or NAMPT inhibitor FK866 (Tocris Bioscience) was administrated 30 minutes before HBO treatment. The vehicle group was given 5% dimethyl sulfoxide (Sigma-Aldrich). Based on previous reports indicating that NAD + administered intraperitoneally at a dosage from 50 to 200 mg/kg have beneficial cytoprotective effects, we used 100 mg/kg, which turn out to be effective in our model. 17, 18 NAMPT inhibitor FK866, was administrated intraperitoneally at a dose of 10 mg/kg as previously described 19 ; Sirt1 siRNAs was administrated intralateroventricularly, 20 and Olig A was administrated 1 mg/mL IP 21
Sirt1 siRNA Injection
Two different formats of Sirt1 siRNAs (OriGene Technologies), to enhance the silencing effect, were applied 48 hours before MCAO via intracerebroventricular injection (ICV). The injections were performed as previously described 20 (online-only Data Supplement).
2,3,5-Triphenyltetrazolium Chloride Staining
The infarct volume was investigated at 24 hours after MCAO via 2,3,5-triphenyltetrazolium chloride staining as described earlier. 22 The possible interference of brain edema on infarct volume was corrected (whole contralateral hemisphere volume-nonischemic ipsilateral hemisphere volume), and the infracted volume was expressed as a ratio of the whole contralateral hemisphere.
Spectrophotometric Assay of Hemoglobin
Hemorrhagic volume was analyzed by hemoglobin assay as previously described 15 (online-only Data Supplement). Hemorrhage measurements were performed on brains already stained with 2,3,5-triphenyltetrazolium chloride for infarct quantification. It has been shown that 2,3,5-triphenyltetrazolium chloride staining does not alter the spectrophotometric hemoglobin assay.
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Brain Water Content
Rats were euthanized under deep anesthesia. The brain samples were quickly removed and dissected on ice into 4 parts: right hemisphere, left hemisphere, cerebellum, and brain stem. The wet weights of tissue samples were measured immediately, and dry weights were obtained after drying in an oven at 105°C for 48 hours. The percentage of brain water content of each part was calculated as [(wet weight−dry weight)/wet weight]×100%.
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Neurological Scores
A neurological examination was performed by a blinded investigator at 24 hours after MCAO as previously described. 24 The scoring system consists of 7 sub-tests (spontaneous activity, symmetry in the movement of 4 limbs, forepaw outstretching, climbing, body proprioception, response to vibrissae touch, and beam walking). The neurological scoring ranged from 3 (most severe deficits) to 21 (normal).
Foot-Fault Test
For testing of motor coordination, foot-fault test was performed by a blinded investigator 24 hours after MCAO as previously described 25 (online-only Data Supplement).
Immunofluorescent Staining
Immunofluorescent staining was performed on fixed frozen ultrathin sections as previously described. 26 Primary antibodies used were neuronal nuclei (Millipore Chemicon International), glial fibrillary acidic protein (Santa Cruz Biotechnology), ionized calcium binding adaptor molecule 1 (Abcam), NAMPT (Santa Cruz Biotechnology), and Sirt1 (Sigma-Aldrich).
Western Blots Analysis
Western blots was performed as previously described. 16 The primary antibodies were NAMPT (Santa Cruz Biotechnology), Sirt1 (Sigma-Aldrich), nuclear factor (NF)-kB-p65 (Sigma-Aldrich), acetyl-p53 (Cell Signaling Technology), cleaved caspase-3 (Cell Signaling Technology).
ELISA for ATP, NAMPT, and NAD +
Brain samples were collected the same way as for Western blots 6 hours after MCAO. ELISA for ATP, NAMPT, and NAD + were performed following the manufacturer's instructions. The levels of ATP and NAD + were assayed with rat ELISA kits of ATP (MyBioSource Inc) and NAD + (BioAssay Systems). The activity of NAMPT was detected with rat ELISA kits of NAMPT (MBL International).
Matrix Metalloproteinase-9 Zymography
Matrix metalloproteinase-9 (MMP-9) zymography was performed as previously described 15 (online-only Data Supplement).
Statistical Analyses
The analysis of the data was performed using GraphPad Prism software. Statistical differences between 2 groups were analyzed using the student's unpaired, 2-tailed t test. Multiple comparisons (without a rating scale) were statistically analyzed with 1-way analysis of variance followed by the Tukey method. The data are presented as means±SEM. Mortality was evaluated by Fisher exact test. In all statistical analysis, a value of P<0.05 represents statistical significance. 
Results
HBO
Sirt1 Colocalized With NAMPT After MCAO and HBO Increased Sirt1 Expression
We determined the localization and time-dependent expression of Sirt1 after MCAO and studied the effects of ATP or NAD + inhibition on the expression of Sirt1. Our results showed that Sirt1 was colocalized with NAMPT in the penumbra 24 hours after MCAO ( Figure 5C ). HBO and NAD + increased the expression of Sirt1 24 hour after MCAO ( Figure 5D ; P<0.05 versus MCAO+DX), NAMPT 
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HBO Showed the Tendency to Decrease Mortality of Hyperglycemic Rats After MCAO
HBO showed the trends to decrease mortality of rats after MCAO+DX. However, the trend did not reach statistical significance ( Figure VI in the online-only Data Supplement).
Discussion
In the present study, we explored the new molecular pathway underlying HBO protection in the model of MCAO-induced HT. The benefits of HBO on HT, observed in our study, are in agreement with previous studies. 9, 10 The novelty and important finding of the study is as follows: the protective effects of HBO are, at least partly, mediated through ATP/NAD + /Sirt1 pathway.
Early restoration of energy can interrupt the initial responses and delay or even disrupt the spiral of abnormal changes that culminate in cell death after ischemic stroke. HBO is able to increase the level of ATP and relieve the energy stress in experimental stroke, [27] [28] [29] but the mechanisms underlying HBOinduced protection have not been fully elucidated yet. In our study, we used the MCAO model, a well-established model of ischemic stroke. We demonstrated that hyperglycemia exaggerated the decrease of the ATP and NAD + level, HT, and neurological deficits in MCAO rats. HBO treatment reduced the infarction volume, as well as hemorrhagic volume, and eventually improved the neurological deficits. Additionally, HBO treatment increased the level of ATP and the activity of NAMPT, promoting the production of NAD + . We further demonstrated for the first time that HBO activated ATP/NAD + / Sirt1 pathway and, consequently, reduced HT and apoptosis.
In clinic, hyperglycemia is more common in patients with preexisting diabetes mellitus; however, it is also present in a significant proportion of nondiabetic patients. 30 Even in the absence of a previous history of diabetes mellitus, ≈60% of acute stroke patients will develop hyperglycemia, which is probably a response to the stress and severity of ischemia. 31 Hyperglycemia is strictly associated with HT and worse clinical outcomes after stroke. 32, 33 Under hyperglycemia condition, anaerobic glucose metabolism can rapidly generate ATP and maintain ATP levels in the ischemic tissue, but this process also produce deleterious lactic acidosis and oxidative stress, which will adversely affect ischemic brain metabolism. 34 In the present study, we injected dextrose at the onset of reperfusion to mimic hyperglycemia in clinic, and our results are consistent with the previous report that acute hyperglycemia further deteriorate the energy status after ischemia. We found the decreased level of ATP and NAD + in the brain, associated with great macroscopic bleeding area and big bleeding volume as well as severe neurobehavioral deficits in the hyperglycemic rats 24 hour after MCAO. Reduction of ATP is the initiator and key mediator of cell death pathways after MCAO. 35 Biochemical studies have consistently shown activation of NAMPT by ATP in vitro, suggesting that cellular energy charge could potentially boost NAMPT-mediated NAD + production. [36] [37] [38] Although mitochondrial membrane potential is an important parameter of mitochondrial function used as an indicator of ATP synthesis, it is hard to access in an in vivo study. 39 We detected the level of intracellular ATP and NAD + alternatively, which reflects the status of cellular energy and energy transformation, as critical moleculars in the pathway we studied. NAD + played an important role in energy balance and cell survival in ischemic stroke. After brain ischemia, NAD + fuels Sirt1 and enables it to regulate transcription factors involved in pathways linked to apoptosis and inflammation. 13 HBO has been reported to increase Sirt1 protein and mRNA expression in animal models of stroke. 14 We found that HBO treatment significantly increased the level of ATP and NAD + , ameliorated HT, and improved neurological functions in hyperglycemic MCAO rats. Administration of NAD + mimicked the effects of HBO. More important, using pharmacological manipulations, this study showed for the first time that HBO positively modulated the activity of NAMPT and upregulated NAD + levels by increasing the level of ATP, thereby, controlled Sirt1 expression, leading to deacetylation of NF-κB and p53. Our results were consistent with the previous studies that inhibition of NAMPT with FK866 13 or silence Sirt1 with Sirt1 siRNA 20 deteriorated the outcome after stroke. We demonstrated a novel ATP/NAD + /Sirt1 signaling pathway of HBO treatment for HT after stroke. Previous studies have demonstrated that HBO increase the oxygen delivery to ischemic tissue and is able to restore energy status of the tissue. 27, 40, 41 We think, therefore, that both direct delivery of oxygen and the activation of ATP/NAD + /Sirt1 pathway underlay HBOinduced BBB protection.
As an NAD + -dependent deacetylase, Sirt1 specifically promotes the transcription of a set of genes related to cell survival, energy metabolism, and inflammation. Sirt1 deficiency or knockdown attenuated the neuroprotection of NAD + in ischemic stroke. 13, 42 Sirt1 mediated deacetylation of p53, reducing its proapoptotic effects, and it also deacetylated NF-κB, reducing its proinflammatory effects. 43 p53 mediates apoptosis through several pathways and results in activation of caspase-3, the executor of cell death. 44 NF-κB is the major transcription factor that transcribes proinflammatory mediators in the nervous system, including MMP-9. In ischemic stroke, MMP-9 is released from neurons and reactive astrocytes to degrade the components of BBB. [45] [46] [47] We showed that in hyperglycemic MCAO rats, Sirt1 was highly colocalized with NAMPT and positively regulated by ATP and NAD + . We also observed that HBO treatment decreased the level of acetylated NF-κB and acetylated p53 in hyperglycemic MCAO rats, and knockdown Sirt1 by Sirt1 siRNA abolished the effects of HBO. Finally, we proved that the beneficial effects were abolished by Sirt1 siRNA. Taken together, we demonstrated that Sirt1 is a key mediator of HBO protective effects.
We investigated whether HBO would be able to decrease injury induced by combination of hyperglycemia/stroke/reperfusion. The combination represents the bright spectrum of human stroke patients with different kind of vascular pathology. Certainly there are differences between cerebral vascular pathophysiology induced by chronic diabetes mellitus-associated hyperglycemia and acute stroke-induced increase of blood glucose. However, there are also significant matches in outcomes and underlying mechanisms between these 2 pathological conditions. Indeed, such factors can be as a result of an increased production of ROS, aggravation of poststroke inflammation, and apoptosis which could be observed both in diabetic and acute hyperglycemic objects. 30, 48, 49 Similarly, there are overlaps in the pathophysiological mechanism underlying BBB injury induced by reperfusion and r-tPA therapy. Both reperfusion and r-tPA can increase the poststroke inflammation and production of ROS and, consequently, disintegrate BBB. [50] [51] [52] We in our study determined a new mechanism underlying HBO-induced protection on BBB after stroke. It is, however, apparent that further detailed investigations of this concept need to be done. Animal models able to mimic diabetes mellitus or r-tPA-induced poststroke injury more precisely should be applied for further investigation.
It is also important to note that massive cerebral infarction is one of the most prominent factors of HT. Therefore, the decrease of the hemorrhagic volume, observed in this study, might not be a consequence of HBO-induced MMP-9 activity reduction, but a consequence of HBO-induced reduction of infarct volume. We have previously proved that the hemorrhagic volume is independent of infarct volume in hyperglycemic MCAO rats. 15 In view of this fact, we think that the decrease of the hemorrhage volume after HBO treatment was mediated by the investigated pathway, but not by the reduction of infarct volume. Furthermore, the effects of ATP/ NAD + /Sirt1 pathway seem to play important role in HBOinduced protection against HT. As mentioned earlier, because of extremely limited supply of energy, neurons in the infarct core die during the first minutes after stroke. It was, therefore, not surprising that HBO has only moderate effects on the infarct volume, probably saving neurons in the peri-infarct penumbra area only. Nevertheless, effects of the HBO can be clearly seen latter. Third, HT is a multifactorial phenomenon. Except the ATP/NAD + /Sirt1 pathway, other mechanisms such as attenuation of increased vascular sensitivity and reactivity may play an important role in the beneficial actions of HBO. 53 HBO induced overexpression of the aquaporin 4, a water channel abundantly expressed in the brain. 54, 55 Effects of HBO on BBB integrity and brain edema might also be mediated by water or ion channels. While some publications show that aquaporin 4 downregulation protects BBB, reducing brain edema, 56 another demonstrated that aquaporin 4 downregulation increases brain water content. 57 Investigations of whether HBO affects the expression of aquaporin 4 and attenuates HT in hyperglycemic MCAO rats are needed. Significant impairment of neurological functions is typical response on development of HT, which has been observed in different models of stroke. 5 We think, therefore, that the beneficial effects of HBO on neurological functions can be explained, at least partly, by the activation of ATP/NAD + /Sirt1 pathway and subsequent preservation of BBB in hyperglycemic MCAO rats.
In conclusion, in this study, we demonstrated that HBO treatment improved energy metabolism and consequently decreased apoptosis and preserved BBB in hyperglycemic rats after ischemic stroke and investigated the possible involvement of ATP/NAD + /Sirt1 pathway in the HBO-induced prevention of HT. Although our results provided first indications that the pathway is involved in the HBO actions, further experiments are needed to strong current results and prove our hypothesis that HBO might be a promising approach for acute ischemic stroke patients, especially diabetic patients and patients treated with r-tPA.
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